TY  - JOUR 
AU  - D., Isla
AU  - J., de Castro
AU  - García Campelo, María del Rosario
AU  - P., Lianes
AU  - E., Felip
AU  - P., Garrido
AU  - L., Paz-Ares
AU  - J.M., Trigo
PY  - 2019
SN  - 1699-048X
UR  - http://hdl.handle.net/20.500.11940/16048
AB  - PURPOSE: Immunotherapy-based approaches are standard first-line treatments for advanced/metastatic lung cancer or for chemoradiotherapy consolidation in locally advanced disease. Uncertainty on how to treat patients at disease progression prompted us...
LA  - eng
KW  - Mutation
KW  - Immunotherapy
KW  - Lung Neoplasms
KW  - Humans
KW  - Consensus
KW  - Antibodies
KW  - Indoles
KW  - Disease Progression
KW  - Antineoplastic Combined Chemotherapy Protocols
TI  - Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus
DO  - 10.1007/s12094-019-02191-y
T2  - Clinical & Translational Oncology
M2  - 759
KW  - CHUAC
VL  - 22
ER  -